Kezar Life Sciences halts mid-stage trial for lupus treatment-February 2024-www.financetom.com

Kezar Life Sciences halts mid-stage trial for lupus treatment

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Kezar Life Sciences halts mid-stage trial for lupus treatment

Oct 2, 2024 11:27 PM

Sept 30 (Reuters) - Kezar Life Sciences ( KZR ) said on

Monday it was stopping enrollment of new patients and dosing of

ongoing patients in its mid-stage study for treating a symptom

of lupus, following the recommendation of an independent

committee after four deaths.

(Reporting by Sneha S K in Bengaluru)

Previous page： Arthur J. Gallagher Buys Bremer Insurance Agencies Next page： Electromed Board Approves Up to $10 Million Share Buyback

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Arthur J. Gallagher Buys Bremer Insurance Agencies

Sep 9, 2025

09:30 AM EDT, 09/09/2025 (MT Newswires) -- Arthur J. Gallagher ( AJG ) said Tuesday it has acquired Old National Bancorp's ( ONB ) Bremer Insurance Agencies unit. Financial terms were not disclosed. ...

Electromed Board Approves Up to $10 Million Share Buyback

Sep 9, 2025

09:27 AM EDT, 09/09/2025 (MT Newswires) -- Electromed ( ELMD ) said Tuesday its board has approved the repurchase of up to $10 million of the company's common stock. The move follows the completion of Electromed's ( ELMD ) previous share buyback authorization in fiscal Q4, the company said. Electromed ( ELMD ) shares were up more than 3% in...

Agnico Eagle Mines Sells Entire Orla Mining Stake for About $405.6 Million

Sep 9, 2025

09:27 AM EDT, 09/09/2025 (MT Newswires) -- Agnico Eagle Mines ( AEM ) said Tuesday it sold its entire 11.3%, or 38 million shares, stake in Orla Mining ( ORLA ) for about 560.5 million Canadian dollars ($405.6 million) through a block trade on the Toronto Stock Exchange at CA$14.75 per share. The company said the divestment allows it to...

BRIEF-Evofem Anticipates Approval Of Merger With Aditxt At Upcoming Stockholder Meeting

Sep 9, 2025

Sept 9 (Reuters) - Aditxt Inc ( ADTX ): * EVOFEM ANTICIPATES APPROVAL OF MERGER WITH ADITXT AT UPCOMING STOCKHOLDER MEETING Source text: Further company coverage: ...